[From the Perspective of a Geriatrician].

Gan To Kagaku Ryoho

General Geriatric Medicine, Kawasaki Medical School.

Published: February 2025

Previous research has revealed that in older patients undergoing cancer treatment, including chemotherapy and surgery, physical or mental/psychological impairment and social background, in addition to clinical condition or organ damage, can affect not only the prognosis but also the health life expectancy. Therefore, in addition to conventional pre-treatment or pre-operative evaluations, geriatric evaluation, such as comprehensive geriatric assessment(CGA)/geriatric assessment (GA)or physical function assessment, i.e., are required to clarify problems specific to older adults and predict their impact on postoperative complications, survival rate, quality of life(QOL), etc. In particular, when a patient is judged to be'frailty', geriatric intervention based on the results of CGA/GA and physical function assessment may improve treatment or postoperative prognosis and QOL, however, the evidence related to this issue is poor, so future investigations are needed. Although the concept of'frailty'differs between the fields of geriatrics and geriatric oncology, they share the common point of not judging older patients undergoing cancer treatment or surgery based solely on their age or appearance but extracting a group in which the disadvantages of treatment or surgery outweigh the benefits. In order to conduct geriatric assessments before cancer treatment or surgery and to make interventions based on the routine assessments, multidisciplinary collaboration conducted by doctors who specialize in geriatrics is essential, so establishing such collaboration would be an urgent task.

Download full-text PDF

Source

Publication Analysis

Top Keywords

cancer treatment
12
treatment surgery
12
older patients
8
patients undergoing
8
undergoing cancer
8
physical function
8
function assessment
8
treatment
5
geriatric
5
[from perspective
4

Similar Publications

The global incidence of biliary tract cancer (BTC) is on the rise, presenting a substantial healthcare challenge. The integration of immune checkpoint inhibitors (ICIs) with molecularly targeted therapies is emerging as a strategy to enhance immune responses. However, the efficacy and underlying mechanisms of these treatments in BTC are still largely unexplored.

View Article and Find Full Text PDF

Background: Robot-assisted thoracoscopic surgery (RATS) is more precise and flexible than video-assisted thoracoscopic surgery (VATS) for early-stage non-small cell lung cancer (NSCLC) treatment. This study compared the early postoperative functional recovery of patients who underwent triportal RATS with that of patients who underwent uniportal video-assisted thoracic surgery (UVATS) for segmentectomy.

Methods: This observational, prospective study included 172 patients with clinical stage I or II peripheral NSCLC who underwent RATS or UVATS segmentectomy.

View Article and Find Full Text PDF

Boron Neutron Capture Therapy (BNCT) leverages the nuclear reaction between boron-10 and thermal neutrons to selectively destroy cancer cells while minimizing damage to surrounding healthy tissues. This therapy has found use in treating glioblastoma, which as a brain cancer, is difficult to treat using conventional radiotherapy, surgery, and chemotherapy due to location and the risk of brain damage. However, to work, the cells must contain 10B.

View Article and Find Full Text PDF

Photodynamic therapy (PDT) has been demonstrated to be an effective tool for cancer treatment. Seeking organelle-targeting photosensitizers (PSs) with robust reactive oxygen species (ROS) production is extremely in demand. Herein, we propose an aggregation-induced photosensitization strategy for effective PDT with osmium complexes.

View Article and Find Full Text PDF

European cancer mortality predictions for the year 2025 with focus on breast cancer.

Ann Oncol

February 2025

Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy. Electronic address:

Background: We predicted the number of cancer deaths and rates for 2025 in the European Union (EU), its five most populous countries, and the UK, focusing on breast cancer.

Materials And Methods: We derived population data and death certificates for all cancers and major sites for the EU, France, Germany, Italy, Poland, Spain, and the UK since 1970, from the World Health Organization and United Nations databases. Estimates for 2025 were computed by linear regression on recent trends identified through Poisson joinpoint regression, considering the slope of the most recent trend segment.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!